Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Asia Spotlight: GSK’s Lamictal, Sanofi’s Lantus Among Latest Round Of China Price Cuts

Jan 14 2013

• By Brian Yang

Related Content

China's NDRC Releases First Set Of Price Cuts; MNCs See Deepest Cuts As Expected

Dec 01 2010

Big Pharma Takes Another Haircut As China Slashes Drug Prices In Two Largest Therapy Fields

Mar 08 2011

With Latest Round Of Cuts, China Continues March To Narrow Gap Between Big Pharma And Local Generics

Aug 05 2011

Related Companies

H. Lundbeck A/S

GSK plc

Johnson & Johnson

Novo Nordisk A/S

Sanofi

Eli Lilly and Company

Novartis AG

AstraZeneca PLC

Boehringer Ingelheim GmbH

Merck & Co., Inc.

Bristol Myers Squibb Company

Sino Biopharmaceutical Limited

Additional Topics

China Asia Pacific Pricing Strategies Reimbursement BioPharmaceutical

More from China

More from Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window